Structure of YM-254890, a Novel Gq/11 Inhibitor from Chromobacterium sp. QS3666

The isolation and structure elucidation of YM-254890, a novel G_q/11 inhibitor from Chromobacterium sp. QS3666, is described. The gross structure was determined by one- and two-dimensional NMR studies and mass spectrometry. YM-254890 is a cyclic depsipeptide containing uncommon amino acids; β-hydroxyleucine (two residues), N,O-dimethylthreonine and N-methyldehydroalanine. YM-254890 exists as a mixture of two conformers in a variety of NMR solvents, and the distinction between major and minor conformers appears to lie in the geometry of the amide bond between 3-phenyllactic acid and N-methyldehydroalanine. The absolute stereochemistery was elucidated by Marfey's analysis and chiral HPLC analysis of the acid hydrolysate of YM-254890.     

Preparation and Photocatalytic Characterization of Nanoporous TiO2

Nanoporous TiO2 photocatalysts were prepared by use of controlled drying method with surfactants. The surface area and porous properties are dependent on the chain length of incorporated surfactant cation. The TiO2 materials prepared in the presence of surfactant molecules during the gel formation exhibit much higher photocatalytic activity than that prepared in the absence of surfactants.     

Synthesis of Two Novel Rhenium（I） Bipyridyl Photosensitive Dyes

Two novel rhenium(I) 2, 2′-bipyridyl complexes, [(4,4′-di-COOEt-bipy) Re(CO)3 (NCCH3)PF6] and [(4,4′-di-COOEt-bipy) Re (CO)3 (NCS)], a model complex [(4,4′-di-COOEt-bipy) Re (CO)3 (pyridine)PF6], were synthesized. Their ground state electronic spectra and emission spectra were measured in acetonitrile. The MLCT absorption maximum of the complex exhibited a considerable red shift as the ligand changed from pyridine to CNCH3, or SCN.     

Ultrasensitive small molecule fluorogenic probe for human heparanase

Heparanase (HPA) is a critical enzyme involved in the remodeling of the extracellular matrix (ECM), and its elevated expression has been linked with diseases such as various types of cancer and inflammation. The detection of heparanase enzymatic activity holds tremendous value in the study of the cellular microenvironment, and search of molecular therapeutics targeting heparanase, however, no structurally defined probes are available for the detection of heparanase activity. Here we present the development of the first ultrasensitive fluorogenic small-molecule probe for heparanase enzymatic activity via tuning the electronic effect of the substrate. The probe exhibits a 756-fold fluorescence turn-on response in the presence of human heparanase, allowing one-step detection of heparanase activity in real-time with a picomolar detection limit. The high sensitivity and robustness of the probe are exemplified in a high-throughput screening assay for heparanase inhibitors.

Heparanase, a critical enzyme involved in the remodeling of the extracellular matrix, activates a disaccharide probe HADP to give a strong fluorescence signal.     

PRODUCTION OF LIGHTOLEFINS FROM CO_2 HYDROGENATION OVER Fe/SILICALITE-2 CATALYST Ⅱ. PROMOTION EFFECT OF MnO PROMOTER

IntroductionItilasbeenshot'-nthattileadditionofMnOpromotertoFocatal}stcanresultinaremarkableimprovementinthesclectivit}'to11ghtalkenesforCOh}!drogenationll'l.Ho-c'cvcr.thecadetofMnOonCH4formationandCOconversionisvery'ambigUouslltolMoreover.MnOpromotergrca…     

A Quantum Chemical Study of N14 Cluster

Ab initio molecular orbital theory and density functional theory have been employed to study N₁₄ cluster with low spin at the HF/6-31G*, B3LYP/6-31G*, B3PW91/6-31G*, BP86/6-31G*, and BHLYP/6-31G* levels of theory. Twelve isomers were studied, including one previously investigated cage molecule. The most stable isomer of N₁₄ is a C _2h -symmetric molecule that contains two separated five-membered nitrogen rings connected by a —N=N—N=N— bridge. The second, third, and fifth most stable isomers each have one five-membered nitrogen ring. The theoretical results suggest that the five-membered nitrogen ring gives rise to a particularly stable structural unit, and the more side chains that the five-membered nitrogen ring links with, the less stable the structure will become.     

含侧链手性噁唑硼烷催化还原苯乙酮对映选择性的理论研究

用AMI方法研究了含侧链手性恶唑硼烷催化苯乙酮还原反应的对映选择性机理 及其取代基和构型对对映选择性的影响。计算结果表明，含侧链手性恶唑硼烷催化 还原苯乙酮的反应机理与Corey等人提出的机理相符合，在此类硼催化剂的作用下 ，苯乙酮还原产物的绝对构型以R型为主。当恶唑硼烷环N(3)，B(2)上无取代基时 ，C(4)，C(5)位的取代基及其构型是不对称催化反应对映选择性的主要影响因素。     

在改进的Ni基催化剂上的甲烷部分氧化制合成气反应

 本文采用高温分解和焙烧硝酸盐的方法合成了一系列Ni基六铝酸盐催化剂BaNiyAl12-yO19-δ (y=0.1、0.3、0.6、0.9和1.0)，并对它们在甲烷部分氧化制合成气反应中的催化性能、催化剂表面积碳及活性组分Ni流失等情况进行了考察。结果表明，该催化剂对甲烷部分氧化制合成气反应具有较好的催化活性，在850 ℃，甲烷转化率和CO选择性分别可达92%和95%。并且催化剂BaNiyAl12-yO19-δ (y=0.3)在100小时的POM反应后，催化剂表面积碳很少，积碳量仅为样品净重的0.8%，特别是100小时反应后，催化剂表面活性组分Ni没有发生流失。这种低积碳量和无活性组分Ni流失与催化剂结构中Ni与相邻原子间的强相互作用有关。     

β-内酰胺类抗生素酶促合成新进展

β-内酰胺类抗生素的合成在制药工业中占据重要的地位, 相关的酶促合成方法研究备受关注; 酶促合成显著提高合成效率, 减少三废的排放, 是实现绿色合成的有效方法. 综述了近年来β-内酰胺类抗生素酶促合成研究的新进展, 包括一锅合成法、原位产物排出法、介质技术和酶固定化方法.     

Terpenoids from the Roots of Ligularia muliensis

Three new eremophilane‐type sesquiterpenes, (6β,8α)‐6‐(acetyloxy)‐8‐hydroxyeremophil‐7(11)‐en‐12,8‐olide ( 1 ), (6α,8α)‐6‐hydroxyeremophil‐7(11)‐en‐12,8‐olide ( 2 ), and (6α,8α)‐6‐(acetyloxy)eremophil‐7(11)‐en‐12,8‐olide ( 3 ) ((8α)‐eremophil‐7(11)‐en‐12,8‐olide = (4aR,5S,8aR,9aS)‐4a,5,6,7,8,8a,9,9a‐octahydro‐3,4a,5‐trimethylnaphtho[2,3‐b]furan‐2(4H)‐one), besides the recently elucidated eremoligularin ( 4 ) and bieremoligularolide ( 5 ), as well as a new highly oxygenated monoterpene, rel‐(1R,2R,3R,4S,5S)‐p‐menthane‐1,2,3,5‐tetrol ( 12 ), together with six known constituents, i.e., the sesquiterpenes 6 and 7 , the norsesquiterpenes 8 – 10 , and the monoterpene 13 , were isolated from the roots of Ligularia muliensis. In addition, an attempt to dimerize 1 to a bieremophilenolide (Scheme) resulted in the generation of the new derivative (6β,8β)‐6‐(acetyloxy)‐8‐chloroeremophil‐7(11)‐en‐12,8‐olide ( 11 ). The new structures were established by means of detailed spectroscopic analysis (IR, FAB‐, EI‐, or HR‐ESI‐MS as well as 1D‐ and 2D‐NMR experiments). Compounds 4 and 5 were evaluated for their antitumor effects in vitro (Table 3).